NBTX nanobiotix.com: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

The use of AI for particle modeling in bioreactors complements the image of Nanobiotix S.A. (NBTX) as a cutting-edge scientific center, which attracts major investors. The Enterprise Value to EBITDA multiple on GURU.Markets summarizes this synergy, where 0.00 represents the latest level. This helps assess the strategy of enhancing radiotherapy through the partnership with Janssen for the global implementation of NBTXR3.

NBTX Nanobiotix Corp: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 15.11.2026

Rincian metrik lan analitis perusahaan Nanobiotix Corp (NBTX)

- rega saham lan target rega konsensus:

Kutipan saham Nanobiotix SA|NBTX - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Biji pasar Nanobiotix SA|NBTX - Nilai Dipunlarasaken Utang lan Kas

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham Nanobiotix|NBTX - Nilai Aset Bersih|Rasio Nilai Pasar marang Nilai Buku nanobiotix.com|NBTX - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

- data bathi bisnis lan rasio investasi:

NBTX - Bathi pungkasan|Bathi sing dikarepake Nanobiotix S.A.|NBTX - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep Nanobiotix SA|NBTX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Nanobiotix Corp|NBTX - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Nanobiotix|NBTX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nanobiotix.com|NBTX - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nanobiotix S.A.

- informasi babagan volume dodolan lan pendapatan:

NBTX - Total pendapatan perusahaan|Prakiraan volume dodolan Nanobiotix S.A.|NBTX - Rasio rega marang pendapatan|Multiplikator Forward P/S Nanobiotix Corp

Analisis umum perusahaan:Nanobiotix Corp NBTX

The EV/EBITDA multiple determines the real value of a business by excluding the impact of debt load and tax distortions to assess the enterprise's net operating efficiency. By analyzing the current EV/EBITDA level of Nanobiotix S.A. (NBTX), an investor can compare the company's capital expenditures on global oncology clinical trials against the business's generated capacity to timely identify capital impairment risks amid rising borrowings.

Pesaing langsung